Next Article in Journal
Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018
Previous Article in Journal
Slow Drinking of Beer Attenuates Subjective Sedative Feeling in Healthy Volunteers: A Randomized Crossover Pilot Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Methionine Restriction Improves Cognitive Ability by Alleviating Hippocampal Neuronal Apoptosis through H19 in Middle-Aged Insulin-Resistant Mice

1
State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China
2
Center for Food Nutrition and Functional Food Engineering, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
3
Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226019, China
4
College of Life Science, Xinyang Normal University, Xinyang 464000, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Nutrients 2022, 14(21), 4503; https://doi.org/10.3390/nu14214503
Submission received: 21 September 2022 / Revised: 21 October 2022 / Accepted: 22 October 2022 / Published: 26 October 2022
(This article belongs to the Section Proteins and Amino Acids)

Abstract

:
LncRNA H19 has been reported to regulate apoptosis and neurological diseases. Hippocampal neuron apoptosis damages cognitive ability. Methionine restriction (MR) can improve cognitive impairment. However, the effect of MR on hippocampal neuronal apoptosis induced by a high-fat diet (HFD) in middle-aged mice remains unclear. For 25 weeks, middle-aged mice (C57BL/6J) were given a control diet (CON, 0.86% methionine + 4.2% fat), a high-fat diet (HFD, 0.86% methionine + 24% fat), or an HFD + MR diet (HFMR, 0.17% methionine + 24% fat). The HT22 cells were used to establish the early apoptosis model induced by high glucose (HG). In vitro, the results showed that MR significantly improved cell viability, suppressed the generation of ROS, and rescued HT22 cell apoptosis in a gradient-dependent manner. In Vivo, MR inhibited the damage and apoptosis of hippocampal neurons caused by a high-fat diet, reduced hippocampal oxidative stress, improved hippocampal glucose metabolism, relieved insulin resistance, and enhanced cognitive ability. Furthermore, MR could inhibit the overexpression of H19 and caspase-3 induced by HFD, HG, or H2O2 in vivo and in vitro, and promoted let-7a, b, e expression. These results indicate that MR can protect neurons from HFD-, HG-, or H2O2-induced injury and apoptosis by inhibiting H19.

1. Introduction

There is a strong relationship between obesity and cognitive impairment in midlife. HFD-induced metabolic disturbances may promote brain aging and cognitive decline [1]. Long-term HFD has been shown to cause global and hippocampal insulin resistance [2], and this increases with age [3]. MR can extend the lifespan [4], restore a youthful metabolic phenotype in adult mice [5], enhance insulin sensitivity [6], and promote glucose metabolism [7]. Insulin resistance with hyperglycemia and defective insulin signaling results in neurons lacking energy and becoming vulnerable to oxidative damage and apoptosis [8,9,10], accelerates cognitive decline. Studies have shown that the first manifestation of Alzheimer’s disease (AD) is neuronal death, not extracellular amyloid plaques [11]. Therefore, interventions targeting neuronal apoptosis may help to reduce the cognitive risk associated with obesity and aging.
Patients with type 2 diabetes also have cognitive impairment, which is related to the severity of hyperglycemia [12], due to imbalances in glucose metabolism in the brain, particularly in the hippocampus [13]. A significant decrease in glucose metabolism was also observed in AD and amnestic mild cognitive impairment, which may be partly due to oxidative damage of enzymes in glycolysis, tricarboxylic acid cycle, and ATP biosynthesis [14].
H19 is a long non-coding RNA (LncRNA) that does not translate into protein, but can interact with miRNA as a competitive endogenous RNA and participate in the regulation of target gene expression [15]. And it is involved in the regulation of apoptosis and neurological diseases [16,17,18,19]. The expression of H19 is increased in brain injuries induced by AD [20], diabetes [21], ischemia/reperfusion [22], epilepsy [23], and oxygen and glucose deprivation [24]. Furthermore, high expression of H19 is related to neuronal apoptosis. Overexpression of H19 exacerbates status epilepticus (SE)-induced neuronal apoptosis in the hippocampus, whereas inhibition of H19 protects rats from SE-induced cellular damage [25]. In a cellular model of AD, β-amyloid protein increased H19 expression and inhibited cell viability in PC12 cells, while silencing of H19 promoted cell viability and inhibited apoptosis in PC12 cells induced by Aβ25–35 [20]. LncRNA can sponge the microRNAs (miRNAs) and suppress its inhibitory effects [15]. MiRNAs are small non-coding RNAs that regulate gene expression at the post-transcriptional level [26]. Several studies have shown that miRNAs have a role in neurodegenerative disease [27], and are involved in many biological processes such as developmental timing, differentiation, and cell death [28]. The let-7 family is a series of miRNAs that participate in the regulation of apoptosis by targeting caspase-3 mRNA [29,30,31,32].
Previous studies have revealed the effects of methionine restriction (MR) on cognitive deficits at different ages by ameliorating hippocampal inflammation and oxidative stress [33,34,35]. However, the protective effect of MR on hippocampal neuronal apoptosis in middle-aged insulin-resistant mice and its potential mechanisms remain unclear. Methionine is a DNA methyl donor, and MR plays an epigenetic role [36]. By regulating S-adenosylhomocysteine hydrolase, H19 modifies genome-wide DNA methylation [37]. MR can regulate oxidative stress [38,39], whereas H19 expression responds to changes in the level of oxidative stress [40]. Therefore, MR may have some functional association with H19. Recent research has indicated that methionine deficiency can regulate the expression of lncRNA pvt1 in gastric cancer cells [41], indicating that MR has the potential to regulate lncRNA expression.
In this study, we evaluated the effect of H19 on MR in improving HFD-induced hippocampal apoptosis, and we analyzed the interrelation of hippocampal H19, oxidative stress, and miRNAs.

2. Materials and Methods

2.1. Animal Experiment

All studies were approved by the Jiangnan University Animal Care and Use Ethics Committee (JN. No20190530c0840215) and conducted under the National Guidelines for Experimental Animal Welfare. C57BL/6J male mice (8 months old, approximately 32 g) (SCXK (Su) 2018-0008) were purchased from GemPharmatech Co., Ltd. (Nanjing, China) and reared with free water and food in a specific pathogen free (SPF) level laboratory at the Animal Experiment Center of Jiangnan University (Wuxi, China). The 24 mice were randomly and equally divided into three groups (CON, HFD, and HFMR) according to their body weight after 1 week. For 25 weeks, mice were given either a control diet (CON, 0.86% methionine + 4.2% fat), a high-fat diet (HFD, 0.86% methionine + 24% fat), or an HFD + MR diet (HFMR, 0.17% methionine + 24% fat). The formulae for the diets are listed in Table S1. The experiment lasted for 25 weeks, and the body weights of the mice were measured weekly.

2.2. Tests of Novel Object Recognition and Morris Water Maze

In this study, nonspatial recognition memory was assessed using a Novel Object Recognition (NOR) test according to the previously described protocol [42]. The Morris Water Maze (MWM) test was used to assess spatial recognition memory according to a previously described protocol [43].

2.3. TdT-Mediated dUTP Nick End Labeling (TUNEL) Fluorescent Assay and Nissl Staining Assay

Hippocampal apoptosis was detected by TUNEL fluorescent staining using the One- Step TUNEL Apoptosis Assay Kit according to the manufacturer’s instructions (Beyotime, Shanghai, China). DAPI staining was used for nuclei staining. The staining was observed using fluorescence microscopy in a 200× visual field (Olympus Corporation, Tokyo, Japan).
For histological analysis, hippocampal neurons were observed by Nissl staining according to the specification of the Nissl Staining Solution (Beyotime, Shanghai, China). The sections were observed using a microscope in 100×, 200×, and 400× visual fields (Olympus Corporation, Tokyo, Japan).

2.4. Detection of Oxidative Stress Index, ROS Levels, Fasting Glucose, and Fasting Insulin

The levels of malondialdehyde (MDA), superoxide dismutase (SOD), and total antioxidant capacity (T-AOC) in hippocampus were detected using assay kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). Reactive oxygen species (ROS) were tested by the luminol-dependent chemiluminescence method according to the previously described protocol [44]. Fasting glucose was measured using OneTouch Ultra Test Strips (Johnson Medical Equipment and Materials Company Limited, Shanghai, China). Fasting insulin was measured using an ELISA kit (Huijia, Guangzhou, China). Homeostasis model assessment of insulin resistance (HOMA-IR) index = [fasting glucose levels (mmol/L)] × [fasting insulin (mIU/L)]/22.5 [45].

2.5. Cell Culture and Transfection

Mouse hippocampal neuron HT22 cells were purchased from the Chinese Academy of Sciences cell bank (Shanghai, China). HT22 cells were cultured in high-glucose basic DMEM (Gbico, Carlsbad, CA, USA) with 10% FBS (Gbico, Carlsbad, CA, USA) and 1% penicillin-streptomycin solution (10,000 U/mL penicillin and 10 mg/mL streptomycin) (Gbico, Carlsbad, CA, USA). MR (0%, 20%, 40%, 60%, 80%, 90%, 95%, 98%, 100%) was achieved by incubating the HT22 cells in methionine-free DMEM (Gbico, Carlsbad, CA, USA) supplemented with 10% FBS (3.38 mg/L methionine and 1.88 mg/L L-cystine), 1% penicillin-streptomycin solution, L-methionine (27, 21.6, 16.2, 10.8, 5.4, 2.7, 1.35, 0.54, 0 mg/L; Sigma, Louis, MO, USA), L-cystine·2HCl (56, 44.8, 33.6, 22.4, 11.2, 5.6, 2.8, 1.12, 0 mg/L; Sigma, Louis, MO, USA), and L-glutamine (520 mg/L; Sigma, Louis, MO, USA) for up to 12 h. H19-expressing plasmid pEX-3-H19 and pEX-3 empty vectors were designed and sold by GenePharma Co., Ltd. (Suzhou, China). Transfection was conducted using Lipo8000 (Beyotime, Shanghai, China), according to the manufacturer’s protocol. After 48 h of transfection, the transfected cells were intervened with HG or MR.

2.6. Cell Viability Assay

HT22 cell viability was tested using the cell counting kit-8 (CCK-8) assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). HT22 cells were cultured in a 96-well plate (5 × 103 cells/well) for 24 h and then cultured in MR (0−100%) or HG (225 mM) culture medium for 12 h. Then, CCK-8 solution (10 μL/well) was added and incubated for 1.5 h in the CO2 incubator. Absorbance was measured using a microplate reader at 450 nm (Epoch, Biotek, Winooski, VT, USA). Cell viability (%) = [A(treatment) − A(blank)]/[A(control) − A(blank)].

2.7. Measurement of ROS in HT22

ROS levels were measured using 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA), which is a specific ROS proprietary fluorogenic probe. After plate incubation, the prepared DCFH-DA probe (10 μM) was added to each well and incubated for 20 min. The intensity of fluorescence was detected using a fluorescent microplate reader at 488 nm excitation and 525 nm emission (Synergy H4, Biotek, Winooski, VT, USA). The radio of ROS in samples was normalized to the CON group [46]. ROS fluorescence images were photographed using the FITC channel of a wide-field imaging high-connotation system (Image Xpress Micro XLS, Molecular Devices, Sunnyvale, CA, USA).

2.8. Flow Cytometric Examination

The annexin V/PI double staining method was used to quantify the levels of apoptosis in each group. HT22 cells were seeded in six-well plates (5 × 105 cells/well) and incubated for 24 h (37 °C, 5% CO2), and then treated with 225 mM HG with or without different levels of MR for 12 h. After 12 h of culture, the supernatant and adherent cells were collected. A total of 2 × 105 cells were taken and resuspended with 500 µL of binding solution, and then stained with 5 µL of FITC and PI for 10 min at room temperature, followed by detection of the apoptotic cells using flow cytometry (FACSAriaII, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) with 1 × 104 cells in each group.

2.9. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)

Total RNA was purified from the hippocampus of mice and HT22 cells using total RNA extraction reagent (Vazyme, Nanjing, China) according to the manufacturer’s protocol. Total cDNA was synthesized using the HiScript III RT SuperMix for qPCR (+gDNA wiper) reagent kit (Vazyme, Nanjing, China). The Mir-X miRNA first strand was synthesized with the Mir-X miRNA First-Strand Synthesis Kit (Takara Bio USA, Mountain View, CA, USA). qRT-PCR was performed using an AceQ qPCR SYBR Green Master Mix (High ROX Premixed) kit (Vazyme, Nanjing, China) on a Quantagene q225 Real-Time PCR system (kubo Technology Ltd., Beijing, China) according to the manufacturer’s protocol. The relative expression of mRNA or miRNA in each sample was normalized to β-actin (mRNA) or U6 (miRNA) by using the 2−ΔΔCt method. The primer sequences are listed in Table S2.

2.10. Western Blot Analysis

The proteins were extracted from the hippocampus of mice and HT22 cells using RIPA lysis buffer (Beyotime, Shanghai, China). The concentration of protein was determined using a BCA kit (Beyotime, Shanghai, China). The protein was separated by SDS- PAGE, followed by transfer onto PVDF membranes. Subsequently, the membranes were incubated with primary antibodies specific for caspase-3 or β-actin (1:1000, Abcam). Then the membranes were incubated with secondary antibodies (1:10,000, Abcam), and bands were visualized with an ECL Chemiluminescent Substrate Reagent kit (Beyotime, Shanghai, China). Image J software was used to analyze the bands, and the expression ratios were normalized to β-actin.

2.11. Statistical Analysis

All data were analyzed using IBM SPSS 20.0 software. The data were expressed as the mean ± standard error of the mean (SEM). The difference between groups was evaluated using one-way ANOVA followed by a Dunnett’s multiple comparisons test. A p-value of <0.05 indicated a significant difference.

3. Results

3.1. MR Improved Cognitive Ability in HFD-Induced Insulin-Resistant Mice

Many studies have shown that a long-term HFD can cause cognitive decline [47]. The NOR and MWM tests were used to examine how MR affected the cognitive ability of middle-aged mice fed with HFD.
The nonspatial recognition memory ability of mice was assessed by the time difference between exploring old (OA) and new objects (OB) in the NOR (Figure 1A). During the test, as shown in Figure 1D, mice in the CON group and HFMR group spent significantly more time exploring OB than OA (p < 0.05), while it was not significantly different in the HFD group (p > 0.05). The tracking paths (Figure 1B) showed that the mice in the CON and HFMR groups rather than the HFD group tended more toward OB. Furthermore, as shown in Figure 1E, by calculating the discrimination index (DI), it can be seen that the DI of the HFD group was significantly lower than that of the CON and HFMR groups (p < 0.05).
The MWM (Figure 1F) is a classic test of spatial recognition memory. As shown in Figure 1H, the HFD group mice took significantly more time to find the platform after the fourth day compared with the CON group (p < 0.05), and mice in the HFMR group effectively reduced the time to find the platform (p < 0.05). Meanwhile, in the probe trial (Figure 1G,J,K), HFMR group mice spent significantly more time in the target quadrant and crossed the platform more frequently than HFD group mice (p < 0.05), and the motion paths of the CON and HFMR group mice were mainly distributed in the platform quadrant, while the HFD group mice moved without a target. Therefore, MR can restore the cognitive ability of the middle-aged mice fed with HFD to be similar to that of the CON group.

3.2. MR Improved Insulin Resistance and Insulin Signaling in HFD Mice

There is sufficient evidence that HFD could lead to systemic insulin resistance, including suppression of insulin signaling in the hippocampus [48]. In this study, HFD significantly increased the levels of fasting glucose, fasting insulin, and HOMA-IR compared to the CON group (p < 0.05, Table 1). Moreover, HFD mice showed insulin resistance symptoms. The MR diet significantly reduced the levels of fasting glucose, fasting insulin and HOMA-IR (p < 0.05) compared to HFD insulin-resistant mice (Table 1).
Glucose serves as the exclusive fuel source for energy production in the brain [49]. Hippocampal glucose metabolism is important for cognitive function, and impaired glucose metabolism in the hippocampus is a risk factor for cognitive impairment [50]. As shown in Figure 2, HFD reduced the glucose metabolism-related mRNA expression of insulin receptor substrate 1 (IRS-1), glucose transporter 1 (GLUT1), hexokinase 2 (HK2) in the hippocampus, compared to the CON group (p < 0.05). However, these mRNA expressions were significantly increased in MR-treated HFD mice. But, the mRNA expression of M2 pyruvate kinase (PKM2) and phosphofructokinase 1 (PFK1) did not present significant differences in the HFD and HFMR groups in comparison to the CON group (p > 0.05).

3.3. MR Improved Hippocampal Oxidative Stress and Inhibited H19 Expression in HFD-Induced Insulin-Resistant Mice

Impaired insulin signaling makes neurons more susceptible to oxidative stress [8]. As shown in Figure 3, HFD significantly increased the levels of MDA and ROS, inhibited the T-AOC and SOD activities and reduced the mRNA expression of NADPH quinineoxidoreductase-1 (NQO-1) and heme oxygenase-1 (HO-1) (p < 0.05). As expected, MR can restore the levels of oxidative stress and ROS to similar to those found in the CON group. Compared with HFD group, MR significantly deceased MDA and ROS levels, increased SOD activity and T-AOC, and promoted the mRNA expression of nuclear factor erythroid-2-related factor 2 (Nrf2), NQO-1 and HO-1 (p < 0.05). Meanwhile, HFD induced H19 overexpression in the hippocampus, whereas MR significantly reduced H19 expression in the HFD insulin-resistant mice (p < 0.05). In addition, there was a strong positive correlation between H19 expression and ROS levels (Figure 3F).

3.4. MR Alleviated Neuronal Injury and Apoptosis in Hippocampus of HFD-Induced Insulin-Resistant Mice

Increased expression of H19 is related to neuronal apoptosis [25]. The results of TUNEL staining showed that a chronic HFD led to significant apoptosis of hippocampal neurons in insulin-resistant mice compared with the CON group (p < 0.01, Figure 4A). HFD-induced apoptosis in the hippocampal was significantly inhibited by MR, which reduced proapoptotic genes (Bcl-2 associated X protein, Bax and cysteinyl aspartate specific proteinase-3, and caspase-3) expression and promoted antiapoptotic genes (B-cell lymphoma 2, Bcl-2) expression (p < 0.05). In addition, MR significantly decreased the protein expression of caspase-3 (p < 0.05).
Photos of the Nissl-stained mice hippocampus are shown in Figure S1. In the CON group, the morphology of hippocampus CA3 neurons was normal, the cytoplasm was rich in Nissl bodies, and the nucleus was clearly visible. In the HFD group, degeneration of and reduction in neurons, nuclear atrophy, and reduction in Nissl bodies were observed. However, MR protected neurons from damage induced by HFD, and it reduced the damaged hippocampal neurons. In this study, the mRNA expression of several neurotrophic factors was investigated to explain the neuroprotective effect of MR against HFD. As shown in Figure S2, HFD significantly downregulated the mRNA expression of brain-derived neurotrophic factor (BDNF), tyrosine kinase receptor B (TRκB), Ca2+/calmodulin-dependent protein kinase II alpha chain (CAMK2A), synaptopodin (Synpo), and cAMP response element-binding protein (CREB) compared with the CON group (p < 0.05). However, the MR diet intervention upregulated these mRNA expressions compared with the HFD group (p < 0.05).

3.5. MR Inhibited the High Expression of H19 Induced by High Glucose in HT22 Cells

To explore the effect of MR on H19, HT22 cells were treated with different MR levels and 225 mM glucose for 12 h. The results of the CCK-8 experiment (Figure 5A) showed that the activity of HT22 cells increased with increasing MR levels when the MR level was less than 80%, but activity decreased when the restriction degree was greater than 80%. Cell viability was strongest at MR80%, and MR inhibited the decrease of cell viability caused by HG (Figure 5B).
As shown in Figure 5, HG increased ROS content (Figure 5D) and H19 expression (Figure 5C) in a concentration-dependent manner, which was inhibited by MR treatment.

3.6. MR Inhibited the High Expression of H19 Induced by ROS in HT22 Cells

Elevated expression of H19 was observed in HFD-fed mice and HT22 cells cultured with different concentrations of HG. Since HFD or HG can cause oxidative stress and ROS production, we suspect that H19 expression increases in response to ROS in hippocampal neurons.
H2O2 is an important ROS [51]. Therefore, to explore the effect of ROS on H19, different concentrations of H2O2 were used to intervene cells for 1 h. As shown in Figure 6A,B, H2O2 increased ROS content and H19 expression in a concentration-dependent manner, with a Pearson correlation coefficient between H19 and ROS of 0.8634 (Figure 6C). MR could significantly inhibit the increase of ROS and restore it to similar to those found in the CON group. In addition, MR significantly inhibited H19 overexpression induced by 0.75 mM H2O2 (p < 0.05, Figure 6D,E,G), and the Pearson correlation coefficient between H19 and ROS was 0.7166 (Figure 6F). These results support our hypothesis that ROS production is related to H19 overexpression in hippocampal neurons.

3.7. MR Inhibited HT22 Cell Apoptosis through Inhibiting H19

Flow cytometry was used to quantify the level of apoptosis. As shown in Figure 7E,G, HG (225mM) significantly increased the apoptosis of HT22 cell compared to the CON group (p < 0.01). Compared with the HG group, MR significantly inhibited apoptosis in a gradient-dependent manner even at high glucose concentrations with apoptosis rates of about 60% (p < 0.01).
MR improved the upregulation of Bax and caspase-3 mRNAs, as well as the downregulation of Bcl-2 mRNA induced by HG in a gradient-dependent manner. A Pearson correlation analysis indicated that there was a positive correlation of H19 with apoptosis, caspase-3, and Bax, but a negative correlation with Bcl-2. Additionally, compared to Bax and Bcl-2, caspase-3, H19, and apoptosis had a greater positive correlation coefficient.
We further investigated the relationship among MR, H19, caspase-3, and apoptosis. The results showed that the mRNA expression of caspase-3 and Bax was significantly upregulated (Figure 8A), the protein expression of caspase-3 (Figure 8B) was significantly upregulated, and the mRNA expression of Bcl-2 was significantly downregulated after H19 was overexpressed (p < 0.05, Figure 8A). It was previously demonstrated that H19 could sponge the let-7 family, and let-7 (let-7 a, b, c, e, f) was specifically targeted to reduce caspase-3 expression [29,30,31,32]. Our results indicated that MR significantly promoted the expression of let-7a-5p, let-7b-5p, and let-7e-5p (Figure 8 F,G), which in turn significantly inhibited the expression of caspase-3 and apoptosis (p < 0.05). In contrast, the opposite result appeared when H19 was overexpressed (Figure 8F). Thus, MR likely inhibited apoptosis in HT22 cells through the H19/let-7/caspase-3 pathway.

4. Discussion

This study found that MR can ameliorate apoptosis of hippocampal neurons and improve cognitive ability. In vitro, we found that MR inhibited ROS generation and apoptosis of HT22 cells induced by HG. This is the first report on the inhibitory effect of MR on apoptosis of hippocampal neurons.
Long-term HFD can cause oxidative stress in the hippocampus and systemic insulin resistance [2,52]. Systemic insulin resistance induces hyperglycemia, and excess glucose causes neurotoxicity by increasing apoptosis and inhibiting cell proliferation, with cognitive impairment [9,10]. Patients with type 2 diabetes also have cognitive impairment [12]. Oxidative stress is an important cause of hippocampal neuron damage, as well as the decline in learning and memory ability [47]. It is because oxidative stress leads to an increase in ROS levels in the hippocampus [52], which leads to neuronal damage and apoptosis [53]. In our results, 25 weeks of HFD increased oxidative stress and ROS levels in the hippocampus, resulted in global insulin resistance, elevated blood glucose, and decreased cognitive ability of mice. There was increased neuronal apoptosis and damaged neurons in the hippocampal CA3 region. In mice fed HFD, MR reduced oxidative stress and ROS levels, inhibited hippocampal neurons apoptosis, improved cognitive ability, improved insulin resistance, decreased blood glucose levels, and restored these too similar to the CON group. At the transcription level, MR increased the expression of glucose metabolism-related mRNA (IRS-1, GLUT1, and HK2) and the expression of learning and memory-related mRNA (BDNF, TRκB, CAMK2A, Synpo, and CREB) in HFD mice.
H19 is one of the first LncRNAs to be identified [54]. It is highly expressed in fetal tissues and can promote embryonic development and growth [55], but its expression is significantly reduced after birth [56]. However, H19 is reactivated in some pathological states, including tissue regeneration, cancer, hypoxia, and CNS disease [57,58]. H19 overexpression significantly increases Bax and caspase-3 expression but decreases Bcl-2 expression, thereby promoting the apoptosis of hippocampal neuronal cells [21]. H19 upregulation induces apoptosis during oxygen and glucose deprivation and reperfusion (OGD/R) via autophagic hyperactivation [59]. Our experimental results in vivo and in vitro showed that H19 was overexpressed in the hippocampus of mice fed HFD and HT22 cells intervened by HG or H2O2. In vitro, HG significantly reduced the viability and increased the apoptosis of HT22 cells. The same findings were observed in vivo, where HFD resulted in hippocampal neuronal apoptosis. Because LncRNA participates in gene regulation at the transcriptional level [60], we detected the expression of apoptosis related mRNA. In vivo, HFD decreased Bcl-2 mRNA expression, increased Bax mRNA expression, and increased caspase-3 mRNA and protein expression. In vitro, HG inhibited Bcl-2 mRNA expression, and promoted Bax and caspase-3 mRNA expression. Moreover, Pearson correlation analysis showed that there was a strong positive correlation between H19 and apoptosis and caspase-3 mRNA expression. Thus, H19 overexpression is associated with hippocampal neuronal apoptosis.
H19 expression responds to changes in oxidative stress [40]. Several studies have shown that H19 increases when cells are exposed to ROS. For example, in cholangiocarcinoma cell lines (QBC939, sk-cha-1, and RBE) and glioma cell lines (U251 and ln229), both short-term and long-term oxidative stress induced by H2O2 or glucose upregulated the expression of H19 in cells [61,62]. In nucleus pulposus cells, an H2O2-induced increase in H19 expression led to cell aging and proliferation suppression, and it stagnated the cell cycle in the G0/G1 phase [46]. Furthermore, H19 overexpression induced by H2O2 was enhanced with increasing ROS levels, and H19 expression could be regulated by modulating ROS levels [63]. In this study, oxidative stress induced by HFD promoted ROS production and H19 expression in the hippocampus, accompanied by neuronal apoptosis. In Vitro, H19 expression in HT22 cells increased with increasing concentrations of H2O2 or glucose and was positively correlated with the ROS levels. However, MR alleviated oxidative stress in mice fed with HFD by promoting SOD activity and T-AOC, reducing MDA and ROS levels, and increasing the mRNA expression of Nrf2, NQO-1, and HO-1, as well as inducing a significant decrease in H19 expression. In vitro, MR was also found to decrease H2O2 or HG-induced ROS accumulation and H19 expression in a gradient-dependent manner. The results showed that HFD or HG promoted the expression of H19 by promoting ROS production. And MR likely regulated H19 expression by ameliorating ROS production.
Neuronal apoptosis was ameliorated after knockdown of H19 in brain injury [20]. In Aβ25–35-induced AD and other brain injuries induced by glucose/oxygen deprivation or hypoxia injury, H19 silencing inhibits the expression of Bax and caspase-3, as well as promotes Bcl-2 expression, thereby inhibiting apoptosis [20,22,24]. In our study, MR inhibited H19 expression by reducing ROS production, ameliorated neuronal apoptosis, inhibited the mRNA and protein expression of caspase-3, reduced Bax mRNA expression, and promoted Bcl-2 mRNA expression in the hippocampus of HFD mice. In vitro studies also revealed that MR could inhibit HG-induced H19 overexpression and apoptosis of HT22 cells and promote cell viability. In addition, MR arranged the neurons orderly and alleviated the morphological abnormalities of neurons in the hippocampal CA3 area of HFD mice. However, after H19 overexpression, the inhibitory effect of MR on apoptosis of HT22 cells was diminished, the mRNA and protein expression of caspase-3 and Bax mRNA expression were increased, and the mRNA expression of Bcl-2 was decreased. Thus, H19 likely mediated the regulatory effects of MR on hippocampal neuronal apoptosis. Although studies have shown that H19 plays an essential function in neuronal regulation and MR has a significant effect on regulating energy metabolism and improving learning and memory ability, this is a new discovery, and no one has previously studied the effect of MR on H19 expression before.
In adult newborn neurons, the let-7 family is abundantly expressed and is implicated in the control of neuronal migration [64]. H19 can regulate the availability of let-7 by acting as a molecular sponge [65]. Some studies have shown that the let-7 family (let-7a, b, c, e, f) binds to the 3′-UTR of caspase-3, inhibits caspase-3 mRNA translation, then inhibits caspase-3 protein expression [29,30,31,32]. At the early stage of AD, neurons show apoptosis, changes in miRNA expression, and caspase-3 expression increases [66]. These studies showed that the let-7 family and caspase-3 were involved in the regulation of neuronal apoptosis and were related to learning and memory ability. In this study, HFD inhibited the expression of let-7a, b, c, e, f, while MR significantly promoted the expression of let-7a, b, e. In vitro, the overexpression of H19 weakened the promotion effect of MR on let-7, along with an increase in caspase-3 expression and apoptosis. Therefore, MR likely inhibited the expression of H19, reduced the combination of H19 and let-7, and increased the expression of let-7a, b, e. The combination of let-7 and caspase-3 reduced the expression of caspase-3 mRNA and protein and inhibited cell apoptosis.

5. Conclusions

In summary, MR can alleviate oxidative stress, and inhibit oxidative stress-induced H19 overexpression in the hippocampus. Then, MR reduces hippocampal neuronal apoptosis through the H19/let-7/caspase-3 pathway (Figure 9), thereby improving the cognitive ability of middle-aged mice fed with HFD. This finding can provide a dietary reference for preventing or alleviating cognitive impairment in the elderly.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu14214503/s1: Table S1. The compositions of the experimental diets (g/100 g); Table S2. Sequences of primers used in quantitative real-time reverse transcription PCR; Figure S1. Effects of MR on neuronal injury in the hippocampus of HFD insulin resistance mice; Figure S2. Effects of MR on learning and memory function-related mRNA in the hippocampus of HFD insulin-resistant mice.

Author Contributions

Conceptualization, C.F. and G.L.; methodology, C.F., Y.J. and G.L.; formal analysis, C.F., Y.J. and G.L.; investigation, C.F., Y.J. and Y.G.; data curation, C.F.; writing—original draft preparation, C.F.; writing—review and editing, C.F., Y.J., X.T., S.L. and G.L.; supervision, Y.S. and G.L.; project administration, C.F. and G.L.; funding acquisition, Y.S. and G.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the China’s 12th Five-Year Plan for Science and Technology Development. The funding number was 2012BAD33B05.

Institutional Review Board Statement

The animal study protocol was approved by the Jiangnan University Animal Care and Use Ethics Committee (protocol code JN. No20190530c0840215 and dated 30 May 2019), and it was conducted under the National Guidelines for Experimental Animal Welfare.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are included in the articles and supplementary documents.

Acknowledgments

The authors thank all the reviewers and editors who participated in the review of this paper.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Uranga, R.M.; Bruce-Keller, A.J.; Morrison, C.D.; Fernandez-Kim, S.O.; Ebenezer, P.J.; Zhang, L.; Dasuri, K.; Keller, J.N. Intersection between metabolic dysfunction, high fat diet consumption, and brain aging. J. Neurochem. 2010, 114, 344–361. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Sa-Nguanmoo, P.; Tanajak, P.; Kerdphoo, S.; Satjaritanun, P.; Wang, X.; Liang, G.; Li, X.; Jiang, C.; Pratchayasakul, W.; Chattipakorn, N.; et al. FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats. Horm. Behav. 2016, 85, 86–95. [Google Scholar] [CrossRef]
  3. Tome-Carneiro, J.; Carmen Crespo, M.; Burgos-Ramos, E.; Tomas-Zapico, C.; Garcia-Serrano, A.; Castro-Gomez, P.; Venero, C.; Pereda-Perez, I.; Baliyan, S.; Valencia, A.; et al. Buttermilk and Krill Oil Phospholipids Improve Hippocampal Insulin Resistance and Synaptic Signaling in Aged Rats. Mol. Neurobiol. 2018, 55, 7285–7296. [Google Scholar] [CrossRef] [PubMed]
  4. Barcena, C.; Quiros, P.M.; Durand, S.; Mayoral, P.; Rodriguez, F.; Caravia, X.M.; Marino, G.; Garabaya, C.; Fernandez-Garcia, M.T.; Kroemer, G.; et al. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism. Cell Rep. 2018, 24, 2392–2403. [Google Scholar] [CrossRef] [Green Version]
  5. Lees, E.K.; Krol, E.; Grant, L.; Shearer, K.; Wyse, C.; Moncur, E.; Bykowska, A.S.; Mody, N.; Gettys, T.W.; Delibegovic, M. Methionine restriction restores a younger metabolic phenotype in adult mice with alterations in fibroblast growth factor 21. Aging Cell 2014, 13, 817–827. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Stone, K.P.; Wanders, D.; Orgeron, M.; Cortez, C.C.; Gettys, T.W. Mechanisms of increased in vivo insulin sensitivity by dietary methionine restriction in mice. Diabetes 2014, 63, 3721–3733. [Google Scholar] [CrossRef] [Green Version]
  7. Luo, T.; Yang, Y.; Xu, Y.; Gao, Q.; Wu, G.; Jiang, Y.; Sun, J.; Shi, Y.; Le, G. Dietary methionine restriction improves glucose metabolism in the skeletal muscle of obese mice. Food Funct. 2019, 10, 2676–2690. [Google Scholar] [CrossRef]
  8. Bosco, D.; Fava, A.; Plastino, M.; Montalcini, T.; Pujia, A. Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis. J. Cell. Mol. Med. 2011, 15, 1807–1821. [Google Scholar] [CrossRef] [Green Version]
  9. Xiang, Q.; Zhang, J.; Li, C.Y.; Wang, Y.; Zeng, M.J.; Cai, Z.X.; Tian, R.B.; Jia, W.; Li, X.H. Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction. Neuropeptides 2015, 54, 9–15. [Google Scholar] [CrossRef]
  10. Suwanjang, W.; Prachayasittikul, S.; Prachayasittikul, V. Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose. PeerJ 2016, 4, e2389. [Google Scholar] [CrossRef]
  11. Lee, J.H.; Yang, D.S.; Goulbourne, C.N.; Im, E.; Stavrides, P.; Pensalfini, A.; Chan, H.; Bouchet-Marquis, C.; Bleiwas, C.; Berg, M.J.; et al. Faulty autolysosome acidification in Alzheimer’s disease mouse models induces autophagic build-up of Abeta in neurons, yielding senile plaques. Nat. Neurosci. 2022, 25, 688–701. [Google Scholar] [CrossRef] [PubMed]
  12. Zilliox, L.A.; Chadrasekaran, K.; Kwan, J.Y.; Russell, J.W. Diabetes and Cognitive Impairment. Curr. Diab. Rep. 2016, 16, 87. [Google Scholar] [CrossRef] [Green Version]
  13. Sickmann, H.M.; Waagepetersen, H.S.; Schousboe, A.; Benie, A.J.; Bouman, S.D. Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis. J. Cereb. Blood Flow Metab. 2010, 30, 1527–1537. [Google Scholar] [CrossRef] [Green Version]
  14. Butterfield, D.A.; Halliwell, B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat. Rev. Neurosci. 2019, 20, 148–160. [Google Scholar] [CrossRef] [PubMed]
  15. Alipoor, B.; Parvar, S.N.; Sabati, Z.; Ghaedi, H.; Ghasemi, H. An updated review of the H19 lncRNA in human cancer: Molecular mechanism and diagnostic and therapeutic importance. Mol. Biol. Rep. 2020, 47, 6357–6374. [Google Scholar] [CrossRef] [PubMed]
  16. Pastori, C.; Wahlestedt, C. Involvement of long noncoding RNAs in diseases affecting the central nervous system. RNA Biol. 2012, 9, 860–870. [Google Scholar] [CrossRef] [Green Version]
  17. Li, L.; Zhuang, Y.; Zhao, X.; Li, X. Long Non-coding RNA in Neuronal Development and Neurological Disorders. Front. Genet. 2018, 9, 744. [Google Scholar] [CrossRef] [Green Version]
  18. Aliperti, V.; Skonieczna, J.; Cerase, A. Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders. Noncoding RNA 2021, 7, 36. [Google Scholar] [CrossRef]
  19. Lim, K.H.; Yang, S.; Kim, S.H.; Chun, S.; Joo, J.Y. Discoveries for Long Non-Coding RNA Dynamics in Traumatic Brain Injury. Biology 2020, 9, 458. [Google Scholar] [CrossRef]
  20. Zhang, Y.Y.; Bao, H.L.; Dong, L.X.; Liu, Y.; Zhang, G.W.; An, F.M. Silenced lncRNA H19 and up-regulated microRNA-129 accelerates viability and restrains apoptosis of PC12 cells induced by Aβ25-35 in a cellular model of Alzheimer’s disease. Cell Cycle 2021, 20, 112–125. [Google Scholar] [CrossRef]
  21. Zhao, Y.H.; Ji, T.F.; Luo, Q.; Yu, J.L. Long non-coding RNA H19 induces hippocampal neuronal apoptosis via Wnt signaling in a streptozotocin-induced rat model of diabetes mellitus. Oncotarget 2017, 8, 64827–64839. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Li, H.; Tang, C.; Wang, D. LncRNA H19 promotes inflammatory response induced by cerebral ischemia-reperfusion injury through regulating the miR-138-5p-p65 axis. Biochem. Cell Biol. 2020, 98, 525–536. [Google Scholar] [CrossRef] [PubMed]
  23. Han, C.L.; Ge, M.; Liu, Y.P.; Zhao, X.M.; Wang, K.L.; Chen, N.; Meng, W.J.; Hu, W.; Zhang, J.G.; Li, L.; et al. LncRNA H19 contributes to hippocampal glial cell activation via JAK/STAT signaling in a rat model of temporal lobe epilepsy. J. Neuroinflamm. 2018, 15, 103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Chen, Z.; Chen, X.; Guo, R.; Meng, J. Protective effects of lncRNA H19 silence against hypoxia-induced injury in PC-12 cells by regulating miR-28. Int. J. Biol. Macromol. 2019, 121, 546–555. [Google Scholar] [CrossRef] [PubMed]
  25. Han, C.L.; Ge, M.; Liu, Y.P.; Zhao, X.M.; Wang, K.L.; Chen, N.; Hu, W.; Zhang, J.G.; Li, L.; Meng, F.G. Long non-coding RNA H19 contributes to apoptosis of hippocampal neurons by inhibiting let-7b in a rat model of temporal lobe epilepsy. Cell Death Dis. 2018, 9, 617. [Google Scholar] [CrossRef]
  26. Pu, M.; Chen, J.; Tao, Z.; Miao, L.; Qi, X.; Wang, Y.; Ren, J. Regulatory network of miRNA on its target: Coordination between transcriptional and post-transcriptional regulation of gene expression. Cell. Mol. Life Sci. 2019, 76, 441–451. [Google Scholar] [CrossRef]
  27. Juzwik, C.A.; Drake, S.S.; Zhang, Y.; Paradis-Isler, N.; Sylvester, A.; Amar-Zifkin, A.; Douglas, C.; Morquette, B.; Moore, C.S.; Fournier, A.E. microRNA dysregulation in neurodegenerative diseases: A systematic review. Prog. Neurobiol. 2019, 182, 101664. [Google Scholar] [CrossRef]
  28. Jovanovic, M.; Hengartner, M.O. miRNAs and apoptosis: RNAs to die for. Oncogene 2006, 25, 6176–6187. [Google Scholar] [CrossRef] [Green Version]
  29. Han, L.; Zhou, Y.; Zhang, R.; Wu, K.; Lu, Y.; Li, Y.; Duan, R.; Yao, Y.; Zhu, D.; Jia, Y. MicroRNA Let-7f-5p Promotes Bone Marrow Mesenchymal Stem Cells Survival by Targeting Caspase-3 in Alzheimer Disease Model. Front. Neurosci. 2018, 12, 333. [Google Scholar] [CrossRef] [Green Version]
  30. Ni, J.; Wang, X.; Chen, S.; Liu, H.; Wang, Y.; Xu, X.; Cheng, J.; Jia, J.; Zhen, X. MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain. Behav. Immun. 2015, 49, 75–85. [Google Scholar] [CrossRef]
  31. Peng, G.; Yuan, Y.; He, Q.; Wu, W.; Luo, B.Y. MicroRNA let-7e regulates the expression of caspase-3 during apoptosis of PC12 cells following anoxia/reoxygenation injury. Brain Res. Bull. 2011, 86, 272–276. [Google Scholar] [CrossRef] [PubMed]
  32. Tsang, W.P.; Kwok, T.T. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 2008, 13, 1215–1222. [Google Scholar] [CrossRef] [PubMed]
  33. Xu, Y.; Yang, Y.; Sun, J.; Zhang, Y.; Luo, T.; Li, B.; Jiang, Y.; Shi, Y.; Le, G. Dietary methionine restriction ameliorates the impairment of learning and memory function induced by obesity in mice. Food Funct. 2019, 10, 1411–1425. [Google Scholar] [CrossRef] [PubMed]
  34. Wu, G.; Han, L.; Shi, Y.; Feng, C.; Yan, B.; Sun, J.; Tang, X.; Le, G. Effect of different levels of dietary methionine restriction on relieving oxidative stress and behavioral deficits in middle-aged mice fed low-, medium-, or high-fat diet. J. Funct. Foods 2020, 65, 103782. [Google Scholar] [CrossRef]
  35. Ren, B.; Wang, L.; Shi, L.; Jin, X.; Liu, Y.; Liu, R.H.; Yin, F.; Cadenas, E.; Dai, X.; Liu, Z.; et al. Methionine restriction alleviates age-associated cognitive decline via fibroblast growth factor 21. Redox Biol. 2021, 41, 101940. [Google Scholar] [CrossRef]
  36. Latimer, M.N.; Freij, K.W.; Cleveland, B.M.; Biga, P.R. Physiological and Molecular Mechanisms of Methionine Restriction. Front. Endocrinol. 2018, 9, 217. [Google Scholar] [CrossRef] [Green Version]
  37. Zhou, J.; Yang, L.; Zhong, T.; Mueller, M.; Men, Y.; Zhang, N.; Xie, J.; Giang, K.; Chung, H.; Sun, X.; et al. H19 lncRNA alters DNA methylation genome wide by regulating S-adenosylhomocysteine hydrolase. Nat. Commun. 2015, 6, 10221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Kitada, M.; Ogura, Y.; Monno, I.; Xu, J.; Koya, D. Effect of Methionine Restriction on Aging: Its Relationship to Oxidative Stress. Biomedicines 2021, 9, 130. [Google Scholar] [CrossRef]
  39. Maddineni, S.; Nichenametla, S.; Sinha, R.; Wilson, R.P.; Richie, J.P. Methionine restriction affects oxidative stress and glutathione-related redox pathways in the rat. Exp. Biol. Med. 2013, 238, 392–399. [Google Scholar] [CrossRef]
  40. Ghafouri-Fard, S.; Shoorei, H.; Taheri, M. Non-coding RNAs are involved in the response to oxidative stress. Biomed. Pharmacother. 2020, 127, 110228. [Google Scholar] [CrossRef]
  41. Xin, L.; Lu, H.; Liu, C.; Zeng, F.; Yuan, Y.W.; Wu, Y.; Wang, J.L.; Wu, D.Z.; Zhou, L.Q. Methionine deficiency promoted mitophagy via lncRNA PVT1-mediated promoter demethylation of BNIP3 in gastric cancer. Int. J. Biochem. Cell Biol. 2021, 141, 106100. [Google Scholar] [CrossRef]
  42. Win-Shwe, T.T.; Fujimaki, H. Acute administration of toluene affects memory retention in novel object recognition test and memory function-related gene expression in mice. J. Appl. Toxicol. 2012, 32, 300–304. [Google Scholar] [CrossRef] [PubMed]
  43. Bromley-Brits, K.; Deng, Y.; Song, W. Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J. Vis. Exp. 2011, 53, 2920. [Google Scholar] [CrossRef] [PubMed]
  44. Kobayashi, H.; Gil-Guzman, E.; Mahran, A.M.; Sharma, R.K.; Nelson, D.R.; Thomas, A.J.; Agarwal, A. Quality control of reactive oxygen species measurement by luminol-dependent chemiluminescence assay. J. Androl. 2001, 22, 568–574. [Google Scholar] [CrossRef]
  45. Xiao, F.; Yu, J.; Guo, Y.; Deng, J.; Li, K.; Du, Y.; Chen, S.; Zhu, J.; Sheng, H.; Guo, F. Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice. Metabolism 2014, 63, 841–850. [Google Scholar] [CrossRef]
  46. Wang, X.B.; Zou, M.X.; Li, J.; Wang, B.; Zhang, Q.S.; Liu, F.B.; Lu, G.H. LncRNA H19 targets miR-22 to modulate H2O2-induced deregulation in nucleus pulposus cell senescence, proliferation, and ECM synthesis through Wnt signaling. J. Cell. Biochem. 2018, 119, 4990–5002. [Google Scholar] [CrossRef] [PubMed]
  47. Tan, B.L.; Norhaizan, M.E. Effect of High-Fat Diets on Oxidative Stress, Cellular Inflammatory Response and Cognitive Function. Nutrients 2019, 11, 2579. [Google Scholar] [CrossRef] [Green Version]
  48. Mulati, A.; Ma, S.; Zhang, H.; Ren, B.; Zhao, B.; Wang, L.; Liu, X.; Zhao, T.; Kamanova, S.; Sair, A.T.; et al. Sea-Buckthorn Flavonoids Alleviate High-Fat and High-Fructose Diet-Induced Cognitive Impairment by Inhibiting Insulin Resistance and Neuroinflammation. J. Agric. Food Chem. 2020, 68, 5835–5846. [Google Scholar] [CrossRef]
  49. Abdul-Ghani, M.A.; DeFronzo, R.A. Pathogenesis of insulin resistance in skeletal muscle. J. Biomed. Biotechnol. 2010, 2010, 476279. [Google Scholar] [CrossRef] [Green Version]
  50. Soya, M.; Jesmin, S.; Shima, T.; Matsui, T.; Soya, H. Dysregulation of Glycogen Metabolism with Concomitant Spatial Memory Dysfunction in Type 2 Diabetes: Potential Beneficial Effects of Chronic Exercise. In Brain Glycogen Metabolism; DiNuzzo, M., Schousboe, A., Eds.; Springer International Publishing: Cham, Switzerland, 2019; pp. 363–383. [Google Scholar] [CrossRef]
  51. Xu, L.; Zhang, Y.; Zhao, L.; Han, H.; Zhang, S.; Huang, Y.; Wang, X.; Song, D.; Ma, P.; Ren, P.; et al. A neoteric dual-signal colorimetric fluorescent probe for detecting endogenous/exogenous hydrogen peroxide in cells and monitoring drug-induced hepatotoxicity. Talanta 2021, 233, 122578. [Google Scholar] [CrossRef]
  52. Zhuang, J.; Lu, J.; Wang, X.; Wang, X.F.; Hu, W.C.; Hong, F.S.; Zhao, X.X.; Zheng, Y.L. Purple sweet potato color protects against high-fat diet-induced cognitive deficits through AMPK-mediated autophagy in mouse hippocampus. J. Nutr. Biochem. 2019, 65, 35–45. [Google Scholar] [CrossRef] [PubMed]
  53. Pugazhenthi, S.; Nesterova, A.; Jambal, P.; Audesirk, G.; Kern, M.; Cabell, L.; Eves, E.; Rosner, M.R.; Boxer, L.M.; Reusch, J.E. Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. J. Neurochem. 2003, 84, 982–996. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Keniry, A.; Oxley, D.; Monnier, P.; Kyba, M.; Dandolo, L.; Smits, G.; Reik, W. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat. Cell Biol. 2012, 14, 659–665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Dey, B.K.; Pfeifer, K.; Dutta, A. The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev. 2014, 28, 491–501. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Zhang, N.; Geng, T.; Wang, Z.; Zhang, R.; Cao, T.; Camporez, J.P.; Cai, S.Y.; Liu, Y.; Dandolo, L.; Shulman, G.I.; et al. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia. JCI Insight 2018, 3, e120304. [Google Scholar] [CrossRef] [Green Version]
  57. Xu, J.; Wang, C.; Meng, F.; Xu, P. Long noncoding RNA H19 inhibition ameliorates oxygen-glucose deprivation-induced cell apoptosis and inflammatory cytokine expression by regulating the microRNA29b/SIRT1/PGC1alpha axis. Mol. Med. Rep. 2021, 23, 131. [Google Scholar] [CrossRef]
  58. Zhong, L.; Liu, P.; Fan, J.; Luo, Y. Long non-coding RNA H19: Physiological functions and involvements in central nervous system disorders. Neurochem. Int. 2021, 148, 105072. [Google Scholar] [CrossRef]
  59. Wang, J.; Cao, B.; Han, D.; Sun, M.; Feng, J. Long Non-coding RNA H19 Induces Cerebral Ischemia Reperfusion Injury via Activation of Autophagy. Aging Dis. 2017, 8, 71–84. [Google Scholar] [CrossRef] [Green Version]
  60. Statello, L.; Guo, C.-J.; Chen, L.-L.; Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 2021, 22, 96–118. [Google Scholar] [CrossRef]
  61. Wang, W.T.; Ye, H.; Wei, P.P.; Han, B.W.; He, B.; Chen, Z.H.; Chen, Y.Q. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. J. Hematol. Oncol. 2016, 9, 117. [Google Scholar] [CrossRef] [Green Version]
  62. Duan, S.; Li, M.; Wang, Z.; Wang, L.; Liu, Y. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling. Onco. Targets Ther. 2018, 11, 6395–6404. [Google Scholar] [CrossRef] [Green Version]
  63. Di Sanzo, M.; Chirillo, R.; Aversa, I.; Biamonte, F.; Santamaria, G.; Giovannone, E.D.; Faniello, M.C.; Cuda, G.; Costanzo, F. shRNA targeting of ferritin heavy chain activates H19/miR-675 axis in K562 cells. Gene 2018, 657, 92–99. [Google Scholar] [CrossRef] [PubMed]
  64. Petri, R.; Pircs, K.; Jonsson, M.E.; Akerblom, M.; Brattas, P.L.; Klussendorf, T.; Jakobsson, J. let-7 regulates radial migration of new-born neurons through positive regulation of autophagy. EMBO J. 2017, 36, 1379–1391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Kallen, A.N.; Zhou, X.B.; Xu, J.; Qiao, C.; Ma, J.; Yan, L.; Lu, L.; Liu, C.; Yi, J.S.; Zhang, H.; et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell 2013, 52, 101–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Płóciennik, A.; Prendecki, M.; Zuba, E.; Siudzinski, M.; Dorszewska, J. Activated Caspase-3 and Neurodegeneration and Synaptic Plasticity in Alzheimer’s Disease. Adv. Alzheimer Dis. 2015, 4, 63–77. [Google Scholar] [CrossRef]
Figure 1. Effects of MR on cognitive ability in HFD-induced insulin-resistant mice. (A) Diagram of the NOR. (B) Tracking paths of mice in NOR. (C) Time to explore objects during training. (D) Time to explore objects during the test. (E) Discrimination index (DI). (F) Diagram of the MWM. (G) Tracking paths of mice in MWM. (H) Latency in the platform hiding period. (I) Speed and latency in the platform visibility period. (J) Number of entries into the platform quadrant and the platform in the platform hiding period. (K) Staying time and moving distance in the platform quadrant during the platform hiding period. All data are shown as the mean ± SEM (n = 8). # p < 0.05 (HFD vs. CON); * p < 0.05 (HFMR vs. HFD).
Figure 1. Effects of MR on cognitive ability in HFD-induced insulin-resistant mice. (A) Diagram of the NOR. (B) Tracking paths of mice in NOR. (C) Time to explore objects during training. (D) Time to explore objects during the test. (E) Discrimination index (DI). (F) Diagram of the MWM. (G) Tracking paths of mice in MWM. (H) Latency in the platform hiding period. (I) Speed and latency in the platform visibility period. (J) Number of entries into the platform quadrant and the platform in the platform hiding period. (K) Staying time and moving distance in the platform quadrant during the platform hiding period. All data are shown as the mean ± SEM (n = 8). # p < 0.05 (HFD vs. CON); * p < 0.05 (HFMR vs. HFD).
Nutrients 14 04503 g001
Figure 2. Effects of MR on insulin signaling in the hippocampus of HFD-induced obesity mice. All data are shown as the mean ± SEM (n = 8). # p < 0.05, (HFD vs. CON); * p < 0.05 (HFMR vs. HFD).
Figure 2. Effects of MR on insulin signaling in the hippocampus of HFD-induced obesity mice. All data are shown as the mean ± SEM (n = 8). # p < 0.05, (HFD vs. CON); * p < 0.05 (HFMR vs. HFD).
Nutrients 14 04503 g002
Figure 3. Effects of MR on hippocampal oxidative stress and H19 expression in HFD-induced insulin-resistant mice. (A) MDA level of the hippocampus. (B) SOD level of the hippocampus. (C) T-AOC level of the hippocampus. (D) Relative ROS level of the hippocampus. (E) Relative H19 expression in the hippocampus. (F) Pearson correlation coefficient between ROS and H19. (G) Nrf2 signaling pathway-related mRNA expression. All data are shown as the mean ± SEM (n = 8). # p < 0.05 (HFD vs. CON); * p < 0.05 (HFMR vs. HFD).
Figure 3. Effects of MR on hippocampal oxidative stress and H19 expression in HFD-induced insulin-resistant mice. (A) MDA level of the hippocampus. (B) SOD level of the hippocampus. (C) T-AOC level of the hippocampus. (D) Relative ROS level of the hippocampus. (E) Relative H19 expression in the hippocampus. (F) Pearson correlation coefficient between ROS and H19. (G) Nrf2 signaling pathway-related mRNA expression. All data are shown as the mean ± SEM (n = 8). # p < 0.05 (HFD vs. CON); * p < 0.05 (HFMR vs. HFD).
Nutrients 14 04503 g003
Figure 4. Effects of MR on neuronal apoptosis in the hippocampus of HFD-induced insulin-resistant mice. (A) TUNEL fluorescent assay of the hippocampus (200×). (B) mRNA expression of apoptosis-related genes. (C) The number of TUNEL-positive cells. (D) Relative protein expression of caspase-3 in hippocampus. (E) Caspase-3 western blotting bands. All data are shown as the mean ± SEM (n = 8). # p < 0.05, ## p < 0.01 (HFD vs. CON); * p < 0.05, ** p < 0.01 (HFMR vs. HFD).
Figure 4. Effects of MR on neuronal apoptosis in the hippocampus of HFD-induced insulin-resistant mice. (A) TUNEL fluorescent assay of the hippocampus (200×). (B) mRNA expression of apoptosis-related genes. (C) The number of TUNEL-positive cells. (D) Relative protein expression of caspase-3 in hippocampus. (E) Caspase-3 western blotting bands. All data are shown as the mean ± SEM (n = 8). # p < 0.05, ## p < 0.01 (HFD vs. CON); * p < 0.05, ** p < 0.01 (HFMR vs. HFD).
Nutrients 14 04503 g004
Figure 5. Effects of MR on the expression of H19 induced by high glucose in HT22 cells. (A) HT22 cell viability treated with different levels of MR. (B) HT22 cell viability treated with HG (225 mM) and different levels of MR. (C) Relative H19 expression of HT22 cells treated with different concentrations of glucose and different levels of MR. (D) Relative ROS levels of HT22 cells treated with different concentrations of glucose and different levels of MR. (E) DCFH fluorescence in HT22 cells treated with HG (225 mM) and different levels of MR. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON); * p < 0.05, ** p < 0.01 (vs. HG).
Figure 5. Effects of MR on the expression of H19 induced by high glucose in HT22 cells. (A) HT22 cell viability treated with different levels of MR. (B) HT22 cell viability treated with HG (225 mM) and different levels of MR. (C) Relative H19 expression of HT22 cells treated with different concentrations of glucose and different levels of MR. (D) Relative ROS levels of HT22 cells treated with different concentrations of glucose and different levels of MR. (E) DCFH fluorescence in HT22 cells treated with HG (225 mM) and different levels of MR. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON); * p < 0.05, ** p < 0.01 (vs. HG).
Nutrients 14 04503 g005
Figure 6. Effects of MR on the high expression of H19 induced by ROS in HT22 cells. (A) Relative ROS levels induced by different concentrations of H2O2 in HT22 cells. (B) Relative H19 expression in HT22 cells treated with different concentrations of H2O2. (C) Pearson correlation between H19 and ROS in HT22 cells treated with different concentrations of H2O2. (D) Relative ROS levels in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. (E) Relative expression of H19 in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. (F) Pearson correlation between H19 and ROS in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. (G) DCFH fluorescence in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON); * p < 0.05, ** p < 0.01 (vs. H2O2).
Figure 6. Effects of MR on the high expression of H19 induced by ROS in HT22 cells. (A) Relative ROS levels induced by different concentrations of H2O2 in HT22 cells. (B) Relative H19 expression in HT22 cells treated with different concentrations of H2O2. (C) Pearson correlation between H19 and ROS in HT22 cells treated with different concentrations of H2O2. (D) Relative ROS levels in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. (E) Relative expression of H19 in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. (F) Pearson correlation between H19 and ROS in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. (G) DCFH fluorescence in HT22 cells treated with H2O2 (0.75 mM) and different levels of MR. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON); * p < 0.05, ** p < 0.01 (vs. H2O2).
Nutrients 14 04503 g006
Figure 7. Effects of MR on HT22 cell apoptosis induced by HG. (AD) Relative Bcl-2, caspase-3, Bax mRNA, and H19 expression in HT22 cells treated with HG (225 mM) and different levels of MR. (E,G) The apoptosis of HT22 cells treated with HG (225 mM) and different levels of MR is presented by flow cytometry. (F) Pearson’s correlations among H19, apoptosis, caspase-3, Bcl-2, and Bax. The size and color of the circles in the upper right corner of the matrix indicate the correlation index level (red denoting a positive correlation and blue denoting a negative correlation), while the bottom left corner of the matrix contains the associated correlation index’s numerical value. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON); * p < 0.05, ** p < 0.01 (vs. HG).
Figure 7. Effects of MR on HT22 cell apoptosis induced by HG. (AD) Relative Bcl-2, caspase-3, Bax mRNA, and H19 expression in HT22 cells treated with HG (225 mM) and different levels of MR. (E,G) The apoptosis of HT22 cells treated with HG (225 mM) and different levels of MR is presented by flow cytometry. (F) Pearson’s correlations among H19, apoptosis, caspase-3, Bcl-2, and Bax. The size and color of the circles in the upper right corner of the matrix indicate the correlation index level (red denoting a positive correlation and blue denoting a negative correlation), while the bottom left corner of the matrix contains the associated correlation index’s numerical value. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON); * p < 0.05, ** p < 0.01 (vs. HG).
Nutrients 14 04503 g007
Figure 8. MR inhibited HT22 cell apoptosis likely through H19/let-7/caspase-3 pathway. (A) Relative H19 and mRNA expression in HT22. (B) Caspase-3 western blotting bands. (C,D) The apoptosis of HT22 cells. (E) Relative protein expression of caspase-3 in HT22. (F) Relative miRNA expression in HT22. (G) Relative miRNA expression in hippocampus. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON or HG + empty vector); * p < 0.05, ** p < 0.01 (vs. HFD or HGMR80% + empty vector).
Figure 8. MR inhibited HT22 cell apoptosis likely through H19/let-7/caspase-3 pathway. (A) Relative H19 and mRNA expression in HT22. (B) Caspase-3 western blotting bands. (C,D) The apoptosis of HT22 cells. (E) Relative protein expression of caspase-3 in HT22. (F) Relative miRNA expression in HT22. (G) Relative miRNA expression in hippocampus. All data are shown as the mean ± SEM. # p < 0.05, ## p < 0.01 (vs. CON or HG + empty vector); * p < 0.05, ** p < 0.01 (vs. HFD or HGMR80% + empty vector).
Nutrients 14 04503 g008
Figure 9. The mechanism of MR on improving cognitive ability by reducing hippocampal neuronal apoptosis in middle-aged insulin-resistant mice.
Figure 9. The mechanism of MR on improving cognitive ability by reducing hippocampal neuronal apoptosis in middle-aged insulin-resistant mice.
Nutrients 14 04503 g009
Table 1. Effects of MR on insulin resistance of HFD-induced obese mice.
Table 1. Effects of MR on insulin resistance of HFD-induced obese mice.
CONHFDHFMR
Body weight (g)41.63 ± 1.3353.03 ± 0.31 ##41.28 ± 3.54 **
Fasting glucose (mmol/L)9.56 ± 0.2011.22 ± 0.35 ##9.11 ± 0.26 **
Fasting insulin (mIU/L)7.52 ± 0.208.43 ± 0.30 #7.05 ± 0.24 *
HOMA-IR3.20 ± 0.264.21 ± 0.41 #2.86 ± 0.23 *
All data are shown as the mean ± SEM (n = 8). # p < 0.05, ## p < 0.01 (HFD vs. CON); * p < 0.05, ** p < 0.01 (HFMR vs. HFD).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Feng, C.; Jiang, Y.; Li, S.; Ge, Y.; Shi, Y.; Tang, X.; Le, G. Methionine Restriction Improves Cognitive Ability by Alleviating Hippocampal Neuronal Apoptosis through H19 in Middle-Aged Insulin-Resistant Mice. Nutrients 2022, 14, 4503. https://doi.org/10.3390/nu14214503

AMA Style

Feng C, Jiang Y, Li S, Ge Y, Shi Y, Tang X, Le G. Methionine Restriction Improves Cognitive Ability by Alleviating Hippocampal Neuronal Apoptosis through H19 in Middle-Aged Insulin-Resistant Mice. Nutrients. 2022; 14(21):4503. https://doi.org/10.3390/nu14214503

Chicago/Turabian Style

Feng, Chuanxing, Yuge Jiang, Shiying Li, Yueting Ge, Yonghui Shi, Xue Tang, and Guowei Le. 2022. "Methionine Restriction Improves Cognitive Ability by Alleviating Hippocampal Neuronal Apoptosis through H19 in Middle-Aged Insulin-Resistant Mice" Nutrients 14, no. 21: 4503. https://doi.org/10.3390/nu14214503

APA Style

Feng, C., Jiang, Y., Li, S., Ge, Y., Shi, Y., Tang, X., & Le, G. (2022). Methionine Restriction Improves Cognitive Ability by Alleviating Hippocampal Neuronal Apoptosis through H19 in Middle-Aged Insulin-Resistant Mice. Nutrients, 14(21), 4503. https://doi.org/10.3390/nu14214503

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop